Cartesian Therapeutics, Inc. earnings per share and revenue

RNAC earnings per share for the last quarter are 6.60 USD whereas the estimation was -0.83 USD which accounts for 895.18% surprise. Company revenue for the same period amounts to -585.00 k USD despite the estimated figure of 138.00 k USD. Estimated earnings per share for the next quarter are -0.81 USD, and revenue is expected to reach 2.50 M USD. Also watch annual changes over time to get a bigger picture of RNAC earnings per share and revenue dynamics.